Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7716453

Concept 2018-06-01 to
2018-11-30
2017-06-01 to
2017-11-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
2,327,736,000 JPY
2,265,504,000 JPY
Non-operating income
Non-operating income
60,245,000 JPY
63,095,000 JPY
Non-operating expenses
Non-operating expenses
19,284,000 JPY
24,156,000 JPY
Ordinary profit (loss)
2,368,697,000 JPY
2,304,443,000 JPY
Extraordinary income
Extraordinary income
56,980,000 JPY
20,524,000 JPY
Extraordinary losses
Extraordinary losses
0 JPY
292,000 JPY
Profit (loss) before income taxes
2,425,677,000 JPY
2,324,676,000 JPY
Profit (loss)
1,675,640,000 JPY
1,572,047,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.